Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
DE0005785802
Mon, 05.12.2022
Fresenius Medical Care AG & Co. KGaA
Helen Giza (54) has been appointed Chief Executive Officer of Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, with immediate effect. Previously, she was Deputy CEO of Fresenius Medical Care. The Supervisory Board of Fresenius Medical Care Management AG unanimously appointed her to s [ … ]
Mon, 05.12.2022
Fresenius Medical Care AG & Co. KGaA
Helen Giza (54) has been appointed Chief Executive Officer of Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, with immediate effect. Previously, she was Deputy CEO of Fresenius Medical Care. The Supervisory Board of Fresenius Medical Care Management AG unanimously appointed her to s [ … ]
Sun, 30.10.2022
Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care revises financial outlook for full year 2022 due to delayed effects from improvements in North American Services business in challenging environment
Business development continues to be strongly impacted by highly uncertain macroeconomic environment driving wage and general cost inflation in all reporting segments
Im [ … ]
Sun, 30.10.2022
Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care revises financial outlook for full year 2022 due to delayed effects from improvements in North American Services business in challenging environment
Business development continues to be strongly impacted by highly uncertain macroeconomic environment driving wage and general cost inflation in all reporting segments
Im [ … ]
Wed, 04.05.2022
Fresenius Medical Care AG & Co. KGaA
- Higher than anticipated COVID-19-related excess mortality, but declining throughout the quarter
- Earnings development affected by ongoing significantly elevated labor costs compounded by effects from Omicron in Health Care Services and by increased material and logistics costs in Health Care Products
- Earnings development in EMEA additionally [ … ]
Tue, 03.05.2022
Fresenius Medical Care AG & Co. KGaA
Dr. Carla Kriwet (51) will become the new CEO of Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, on January 1, 2023. The Supervisory Board of Fresenius Medical Care Management AG unanimously appointed her to succeed Rice Powell (66), who in accordance with the company’s age limit fo [ … ]
Mon, 21.03.2022
Fresenius Medical Care AG & Co. KGaA
- Creation of new company combines strengths of three leading value-based care specialists
- Execution on strategic expansion along the renal care continuum significantly expands Fresenius Medical Care's total addressable market in the U.S. from around $50 billion to around $170 billion
- Establishing independent and integrated value-based care off [ … ]
Wed, 23.02.2022
Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, has filed the annual report 2021 on form 20-F with the U.S. Securities and Exchange Commission (SEC). The report is available at the company's website (freseniusmedicalcare.com) in the "Investors" section as well as at the SEC's websit [ … ]
Tue, 22.02.2022
Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, commits to become climate neutral by 2040. This applies both to direct and indirect CO2 emissions (Scope 1 and 2) - also in view of the expected future business growth. The company is also continuously assessing its emissions across th [ … ]
Tue, 22.02.2022
Fresenius Medical Care AG & Co. KGaA
- Business development significantly impacted by COVID-19 in 2021, effects are expected to continue into 2022
- Decline in excess mortality in the fourth quarter
- 25th consecutive dividend increase to 1.35 EUR proposed
- Implementation of strategic priorities on track
Rice Powell, Chief Executive Officer of Fresenius Medical Care, said: "Througho [ … ]